A new case of bacterial endocarditis in a child with severe Haemophilia A carrying a central venous access device

Haemophilia ◽  
2015 ◽  
Vol 21 (3) ◽  
pp. e251-e253 ◽  
Author(s):  
B. De Rueda ◽  
S. Santa Catalina ◽  
F. Lucia ◽  
D. García de la Calzada ◽  
C. Aguilar
Keyword(s):  
Central Venous Access ◽  
Venous Access ◽  
Bacterial Endocarditis ◽  
Haemophilia A ◽  
Severe Haemophilia ◽  
Central Venous ◽  
Central Venous Access Device ◽  
Access Device ◽  
Venous Access Device

Central venous access device insertion and perioperative management of patients with severe haemophilia A

2016 ◽  
Vol 27 (2) ◽  
pp. 156-159 ◽  
Author(s):  
Adriana Fonseca ◽  
Kim Nagel ◽  
Kay Decker ◽  
Mimitha Pukulakatt ◽  
Mohan Pai ◽  
...  
Keyword(s):  
Perioperative Management ◽  
Central Venous Access ◽  
Venous Access ◽  
Haemophilia A ◽  
Severe Haemophilia ◽  
Central Venous ◽  
Central Venous Access Device ◽  
Access Device ◽  
Venous Access Device

Complications associated with central venous access device in children with haemophilia: a nationwide multicentre study in Finland

Haemophilia ◽  
2015 ◽  
Vol 21 (6) ◽  
pp. 747-753 ◽  
Author(s):  
K. Vepsäläinen ◽  
R. Lassila ◽  
M. Arola ◽  
P. Lähteenmäki ◽  
M. Möttönen ◽  
...  
Keyword(s):  
Multicentre Study ◽  
Central Venous Access ◽  
Venous Access ◽  
Haemophilia A ◽  
Central Venous ◽  
Central Venous Access Device ◽  
Access Device ◽  
Venous Access Device

Central venous access device catheter fragmentation at time of removal in four patients with haemophilia A

Haemophilia ◽  
2019 ◽  
Vol 25 (3) ◽  
Author(s):  
Shanna White ◽  
Rohith Jesudas ◽  
Terrance M. Brady ◽  
Michael D. Tarantino
Keyword(s):  
Central Venous Access ◽  
Venous Access ◽  
Haemophilia A ◽  
Central Venous ◽  
Central Venous Access Device ◽  
Access Device ◽  
Venous Access Device

Outpatient central venous access device insertion in very young children with severe haemophilia

2020 ◽  
Vol 31 (7) ◽  
pp. 490-492
Author(s):  
Hedi Bensadok ◽  
Maud Maniora ◽  
Alexandre Théron ◽  
Eric Jeziorski ◽  
Alain Rochette ◽  
...  
Keyword(s):  
Young Children ◽  
Central Venous Access ◽  
Venous Access ◽  
Severe Haemophilia ◽  
Central Venous ◽  
Central Venous Access Device ◽  
Access Device ◽  
Very Young Children ◽  
Venous Access Device

Risk factors determining central venous access device-associated deep vein thrombosis resolution in children: a retrospective study

2021 ◽  
Author(s):  
Miguel García-Boyano ◽  
José Manuel Caballero-Caballero ◽  
Marta García Fernández de Villalta ◽  
Mar Gutiérrez Alvariño ◽  
María Jesús Blanco Bañares ◽  
...  
Keyword(s):  
Risk Factors ◽  
Deep Vein Thrombosis ◽  
Central Venous Access ◽  
Venous Access ◽  
Central Venous ◽  
Central Venous Access Device ◽  
Access Device ◽  
Vein Thrombosis ◽  
Venous Access Device ◽  
Deep Vein

scholarly journals How I treat central venous access device–related upper extremity deep vein thrombosis

Blood ◽  
2017 ◽  
Vol 129 (20) ◽  
pp. 2727-2736 ◽  
Author(s):  
Anita Rajasekhar ◽  
Michael B. Streiff
Keyword(s):  
Central Venous Access ◽  
Vena Cava ◽  
Venous Access ◽  
Postthrombotic Syndrome ◽  
Central Venous ◽  
Central Venous Access Device ◽  
Access Device ◽  
Persistent Symptoms ◽  
Vena Cava Filters ◽  
Venous Access Device

AbstractCentral venous access device (CVAD)-related thrombosis (CRT) is a common complication among patients requiring central venous access as part of their medical care. Complications of CRT include pulmonary embolism, recurrent deep venous thrombosis, loss of central venous access, and postthrombotic syndrome. Patient-, device-, and treatment-related factors can influence the risk of CRT. Despite numerous randomized controlled trials, the clinical benefit of pharmacologic thromboprophylaxis for the prevention of CRT remains to be established. Therefore, minimizing patient exposure to known risk factors is the best available approach to prevent CRT. Venous duplex is recommended for the diagnosis of CRT. Anticoagulation for at least 3 months or the duration of the indwelling CVAD is recommended for treatment of CRT. Thrombolysis should be considered for patients at low risk for bleeding who have limb-threatening thrombosis or whose symptoms fail to resolve with adequate anticoagulation. CVAD removal should be consider for patients with bacteremia, persistent symptoms despite anticoagulation, and if the CVAD is no longer needed. Superior vena cava filters should be avoided. Prospective studies are needed to define the optimal management of patients with or at risk for CRT.

Sign in / Sign up

Export Citation Format

Share Document